Navigation Links
Global Medical Experts to Discuss Knowledge Translation for Integration of Complementary Therapies in Cancer Treatment at Vancouver, BC Conference
Date:9/27/2013

Albany, New York (PRWEB) September 27, 2013

The Society for Integrative Oncology (SIO) is set to examine the growing evidence base for complementary therapies and practices at its 10th International Conference, to be held October 20-22 in Vancouver, British Columbia, Canada at the Fairmont Hotel Vancouver. This evidence involves the rapid translation of scientific literature into today’s standard care and best practice guidelines in the treatment of cancer patients. Medical clinicians in attendance will be encouraged to incorporate into practice the evidence-based approaches presented during the conference.

“This year’s conference theme, From Bedside to Bench to Best Practices, will draw researchers and clinicians, alike, interested in both expanding the science of integrative oncology and how to apply the findings into cancer care. SIO is truly an interdisciplinary and inter-professional organization and its conference fosters dialogue among oncology and integrative medicine practitioners and scientists along with patient advocates,” said SIO President Dr. Susan Bauer-Wu.

Today a significant portion of cancer patients use some type of integrative or complementary therapeutic approaches throughout their cancer journey. In addition to conventional therapies, they want to learn about and utilize an integrative approach to personalized comprehensive care. Integrative oncology interventions have been shown to decrease some of the side effects of traditional cancer treatment, allowing many patients to tolerate their full, prescriptive course, thereby improving clinical outcomes and quality of life. Many health consumers also incorporate lifestyle medicine approaches to help prevent the onset of cancer.

Integrative oncology facilitates cancer treatment and recovery through use of diet and complementary therapeutic options including physical exercise, nutritional supplementation, botanical products, mind-body therapies, acupuncture, massage therapy and more. The options are strategically combined with conventional medical care, including chemotherapy, radiation therapy, surgery and targeted agents informed by genomic and molecular diagnostics.

The 10th International Conference of the Society for Integrative Oncology is presented in association with the University of British Columbia School of Medicine Department of Continuing Medical Education and the UBC School of Nursing. Conference presentations will include topics on physical activity; cancer prevention and survivorship; cannabis in the treatment and management of cancer and related side effects; chemoprevention through natural health products and advances in nutrition therapy, as well as a discussion on the top 10 nutritional supplements for integrating into cancer care.

SIO is the leading worldwide organization dedicated to integrative medicine specific to cancer patients. It is a non-profit, multi-disciplinary organization founded in 2003, with a mission to advance evidence-based, comprehensive, integrative healthcare to improve the lives of people affected by cancer.

For more information or to register for the conference, visit our website integrativeonc.org, or contact the SIO at 347-676-1746.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11169364.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
2. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
3. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
4. StemCyte Adds World Class Talent to its North America and Global Operations
5. Sequenom Named to NASDAQ Global Select Market
6. Synthetic Biology: Emerging Global Markets
7. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
8. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
9. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
10. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
11. Accuray Surpasses 600 Installations Globally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
(Date:6/23/2016)... ... 23, 2016 , ... Supplyframe, the Industry Network for electronics ... Lab . Located in Pasadena, Calif., the Design Lab’s mission is to bring ... designed, built and brought to market. , The Design Lab is Supplyframe’s physical ...
(Date:6/23/2016)... 23, 2016  Blueprint Bio, a company dedicated to ... medical community, has closed its Series A funding round, ... "We have received a commitment from Forentis ... need to meet our current goals," stated Matthew ... runway to complete validation on the current projects in ...
Breaking Biology Technology:
(Date:5/3/2016)... Lithuania , May 3, 2016  Neurotechnology, ... released the MegaMatcher Automated Biometric Identification System ... of large-scale multi-biometric projects. MegaMatcher ABIS can process ... accuracy using any combination of fingerprint, face or ... MegaMatcher SDK and MegaMatcher Accelerator ...
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
Breaking Biology News(10 mins):